Recent Advances in Molecular Biomarkers in Multiple Myeloma - Episode 3

Evidence Around Venetoclax for Patients with t(11;14) Translocation in MM


Drs Shaji Kumar and Jonathan Kaufman review the BELLINI trial, as well as provide an overview of other investigational studies of venetoclax for the treatment of patients with t(11;14) translocation with relapsed refractory multiple myeloma.